Background: Vortioxetine is a novel antidepressant drug that proved effective in the
treatment of major depressive disorder (MDD) and anxiety disorder. It is a unique …

Antidepressants have made major contributions towards the treatment of anxiety and mood
disorders. A variety of pharmacologic classes of these agents emerged since the 1960s …

Vortioxetine (Brintellix®), a serotonin transporter inhibitor and modulator of serotonin
receptor activity, extends the available options for treating major depressive disorder (MDD) …

The plethora of studies indicated that there is a cross talk relationship between harmaline
and serotonergic (5-HT) system on cognitive and non-cognitive behaviors. Thus, the …

La depressione è una delle patologie più frequentemente diagnosticate ed è la seconda
causa di disabilità nel mondo, conseguente all'elevato livello di invalidità (ad esempio …

Major depressive disorder (MDD) affects approximately 350 million people worldwide. MDD
would be the first cause of burden disease in 2030, according to the projections of the World …

El trastorno depresivo mayor es una enfermedad común que a menudo incluye disfunción
cognitiva. El presente artículo, publicado por responsables del departamento de psiquiatría …

This essay investigates the relationship between a malfunctioning Default Mode Network
(DMN) and the diagnosis of Major Depressive Disorder (MDD). A deeper understanding of …

Exercise has been associated with several positive mental health outcomes. Despite
considerable research highlighting the impact of exercise on mental health, less is known …

Mood stabilizers have been used to primarily treat bipolar and schizoaffective disorders.
However, these agents are also employed as adjunctive treatments for schizophrenia …